An observational study in Endometriosis, sponsored by Ipsen. Completed at 7 sites in 3 countries. Open to female participants aged 18 Years to 41 Years. Per ClinicalTrials.gov, last updated 2019-01-14.
Sponsored by Ipsen · Observational
This study will aim to identify genetic, medical, dietary and environmental factors associated with the development of endometrioma and/or deep infiltrating endometriosis in order to move towards early diagnosis and implementation of potential preventative measures.
901 studies on the registry are indexed under Endometriosis; 259 are open to participants now.
This study's enrollment of 1,008 is above the median of 128 across 344 observational studies indexed under Endometriosis.
Browse Endometriosis studies →Ipsen is the lead sponsor of 282 studies on the registry; 16 are open to participants now.
Of its 24 completed or terminated interventional studies of FDA-regulated products, 19 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Women who have undergone a laparoscopy/laparatomy for a benign gynaecological indication excluding pregnancy in the last 3 months.
Exclusion Criteria:
Factors associated with endometrioma and/or deep infiltrating endometriosis using retrospective data collection and patient questionnaire.
Time frame: Enrolment visit
Factors associated with superficial endometriosis using retrospective data collection and patient questionnaire.
Time frame: Enrolment visit
Factors associated with endometrioma and/or deep infiltrating endometriosis according to subject ethnicity using retrospective data collection and patient questionnaire.
Time frame: Enrolment visit
Subject's characteristics by endometriosis status using retrospective data collection and patient questionnaire.
Time frame: Enrolment visit
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ipsen